CD8A and neoplasm: Moreover, the combination of MSC-oHSV with anti-PD-L1 immunotherapy also increased the abundance of tumour-infiltrating IFN-γ-producing CD8+ T cell subpopulation and was associated with a significant increase in the median survival of treated animals [187].